{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:23:52Z","timestamp":1794695032241,"version":"4.9.1"},"reference-count":32,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,11,15]]},"DOI":"10.2169\/internalmedicine.6655-25","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T22:10:32Z","timestamp":1775513432000},"page":"3066-3071","source":"Crossref","is-referenced-by-count":1,"title":["Mesenteric AL Amyloidosis with Diffuse Calcifications: A Case Report and Review of the Literature"],"prefix":"10.2169","volume":"65","author":[{"given":"Yoshiki","family":"Furukawa","sequence":"first","affiliation":[{"name":"Department of Hematology, Juntendo University Nerima Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erina","family":"Hosoya","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Nerima Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Nerima Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Yanashima","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Nerima Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Nerima Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiko","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Nerima Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Hirano","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Nerima Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Ogura","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Juntendo University Nerima Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Nerima Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Palladini G, Merlini G. How I treat AL amyloidosis. Blood 139: 2918-30, 2022.","DOI":"10.1182\/blood.2020008737"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Merlini G, Dispenzieri A, Sanchorawala V, Sch\u00f6nland SO, Palladini G, Hawkins PN, et al. Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Primers 4: 38, 2018.","DOI":"10.1038\/s41572-018-0034-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sanchorawala V. Systemic Light Chain Amyloidosis. N Engl J Med 390: 2295-307, 2024.","DOI":"10.1056\/NEJMra2304088"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Krishnan J, Chu WS, Elrod JP, Frizzera G. Tumoral presentation of amyloidosis (amyloidomas) in soft tissues. A report of 14 cases. Am J Clin Pathol 100: 135-44, 1993.","DOI":"10.1093\/ajcp\/100.2.135"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mohan V, Kemp JA, Lewine HE, Rabin M, Goldstein ML, Farraye FA. Diffuse mesenteric amyloidosis. Dig Dis Sci 42: 1079-82, 1997.","DOI":"10.1023\/A:1018809724577"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Halm U, Berr F, Tannapfel A, Kl\u00f6ppel R, Secknus R, M\u00f6ssner J. Primary amyloidosis of the mesentery and the retroperitoneum presenting with lymphedema. Am J Gastroenterol 93: 2299-300, 1998.","DOI":"10.1111\/j.1572-0241.1998.00647.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Coumbaras M, Chopier J, Massiani MA, Antoine M, Boudgh\u00e8ne F, Bazot M. Diffuse mesenteric and omental infiltration by amyloidosis with omental calcification mimicking abdominal carcinomatosis. Clin Radiol 56: 674-6, 2001.","DOI":"10.1053\/crad.2000.0654"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yin H, Alhasan N, Ciervo A, Zinterhofer L. Soft tissue amyloidoma with features of plasmacytoma: a case report and review. Arch Pathol Lab Med 126: 969-71, 2002.","DOI":"10.5858\/2002-126-0969-STAWFO"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Akl MN, Kho RM, McCullough AE, Collins JM, Lund JT, Magtibay PM. Mesenteric and omental amyloidosis mimicking intraperitoneal carcinomatosis. Surgery 144: 473-5, 2008.","DOI":"10.1016\/j.surg.2008.01.001"},{"key":"10","unstructured":"10. Moleiro C. Mesenteric Amyloidoma: a clinical case report. Internal Medicine Service of the Hospital Distrital de Faro 16: 17-20, 2008."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Coulier B, Montfort L, Doyen V, Gielen I. MDCT findings in primary amyloidosis of the greater omentum and mesentery: a case report. Abdom Imaging 35: 88-91, 2010.","DOI":"10.1007\/s00261-008-9487-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Bhavsar T, Vincent G, Durra H, Khurana JS, Huang Y. Primary amyloidosis involving mesenteric lymph nodes: diagnosis by fine-needle aspiration cytology. Acta Cytol 55: 296-301, 2011.","DOI":"10.1159\/000324181"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Asadi M. Mesenteric amyloid deposition as the initial presentation of multiple myeloma. BMJ Case Rep 2011: 2011.","DOI":"10.1136\/bcr.05.2010.2977"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Vanhoenacker F, Vanwambeke K, Jacomen G. Amyloidosis: an unusual cause of mesenteric, omental and lymph node calcifications. Jbr-btr 97: 283-6, 2014.","DOI":"10.5334\/jbr-btr.1329"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yokota K, Kishida D, Kayano H, Yazaki M, Shimada Y, Akiyama Y, et al. A case of abdominal aortic retroperitoneal and mesenteric amyloid light chain amyloidoma. Case Rep Rheumatol 2016: 4146030, 2016.","DOI":"10.1155\/2016\/4146030"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Alkukhun A, Rezek I, Ghiassi S, Zhang X, Revzin MV. Mesenteric amyloidosis: radiologic imaging with pathologic correlation. J Clin Imaging Sci 10: 24, 2020.","DOI":"10.25259\/JCIS_10_2020"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Duan G, Qi M, Guo Q, Song Z. Primary amyloidosis involving the gastrointestinal tract, mesentery and omentum: A case report. Exp Ther Med 22: 1145, 2021.","DOI":"10.3892\/etm.2021.10579"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Gulwani HV, Vijayvergiya G, Varshney S. Diffuse primary amyloidosis of retroperitoneum and mesenteric fat-treatment and long-term follow-up. Indian Journal of Surgery 86: 442-6, 2024.","DOI":"10.1007\/s12262-023-03858-1"},{"key":"19","unstructured":"19. Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, et al. Daratumumab-based treatment for immunoglobulin light-chain amyloidosis. N Engl J Med 385: 46-58, 2021."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Palladini G, Hegenbart U, Milani P, Kimmich C, Foli A, Ho AD, et al. A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis. Blood 124: 2325-32, 2014.","DOI":"10.1182\/blood-2014-04-570010"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Rybinski B, Kocoglu M. Hepatic AL amyloidosis without significant light chain elevation in a patient treated with CyBorD plus daratumumab. Am J Case Rep 22: e933241, 2021.","DOI":"10.12659\/AJCR.933241"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Palladini G, Russo P, Bosoni T, Verga L, Sarais G, Lavatelli F, et al. Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine. Clin Chem 55: 499-504, 2009.","DOI":"10.1373\/clinchem.2008.117143"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Katzmann JA, Abraham RS, Dispenzieri A, Lust JA, Kyle RA. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. Clin Chem 51: 878-81, 2005.","DOI":"10.1373\/clinchem.2004.046870"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Prokaeva T, Spencer B, Sun F, O'Hara RM, Seldin DC, Connors LH, et al. Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio. Amyloid 23: 214-20, 2016.","DOI":"10.1080\/13506129.2016.1219715"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Dittrich T, Bochtler T, Kimmich C, Becker N, Jauch A, Goldschmidt H, et al. AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis. Blood 130: 632-42, 2017.","DOI":"10.1182\/blood-2017-02-767475"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Zhang C, Zhang Y, Zhu M, Zhang C, Lu D, Jiang J, et al. Amyloid-induced mineralization: From biological systems to biomimetic materials. Bioact Mater 51: 469-93, 2025.","DOI":"10.1016\/j.bioactmat.2025.04.036"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Lee JH, Lee GY, Kim SJ, Kim KH, Jeon ES, Lee KH, et al. Imaging findings and literature review of (18) F-FDG PET\/CT in primary systemic AL amyloidosis. Nucl Med Mol Imaging 49: 182-90, 2015.","DOI":"10.1007\/s13139-015-0338-0"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Glaudemans AW, Slart RH, Noordzij W, Dierckx RA, Hazenberg BP. Utility of 18F-FDG PET (\/CT) in patients with systemic and localized amyloidosis. Eur J Nucl Med Mol Imaging 40: 1095-101, 2013.","DOI":"10.1007\/s00259-013-2375-1"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Coffey JC, O'Leary DP. The mesentery: structure, function, and role in disease. Lancet Gastroenterol Hepatol 1: 238-47, 2016.","DOI":"10.1016\/S2468-1253(16)30026-7"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Yetkin DI, Onur MR, Karadag O, Erden A, Akpinar E, Kosemehmetoglu K. IgG4-related sclerosing disease with mesenteric and retroperitoneal involvement. The Egyptian Journal of Radiology and Nuclear Medicine 48: 767-9, 2017.","DOI":"10.1016\/j.ejrnm.2017.07.009"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Sheth S, Horton KM, Garland MR, Fishman EK. Mesenteric neoplasms: CT appearances of primary and secondary tumors and differential diagnosis. Radiographics 23: 457-73, 2003; quiz 535-6.","DOI":"10.1148\/rg.232025081"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Mindelzun RE, Jeffrey RB Jr, Lane MJ, Silverman PM. The misty mesentery on CT: differential diagnosis. AJR Am J Roentgenol 167: 61-5, 1996.","DOI":"10.2214\/ajr.167.1.8659422"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/22\/65_6655-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:11:19Z","timestamp":1794694279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/22\/65_6655-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11,15]]},"references-count":32,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6655-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,11,15]]},"article-number":"6655-25"}}